Each of the four aromatic -CH= of (S,R)-2-pyrrolidinyl-1,4-benzodioxane [(S,R)-6] and of its epimer at the dioxane stereocenter (S,S)-6, previously reported as alpha4beta2 nAChR ligands, was replaced with nitrogen. The resulting four diastereoisomeric pairs of pyrrolidinyl-pyridodioxanes were studied for the nicotinic affinity and activity at alpha4beta2, alpha3beta4 and alpha7 nAChR subtypes and compared to their common carbaisostere. It turned out that such isosteric substitutions are highly detrimental, but with the important exception of the S,R stereoisomer of the pyrrolidinyl-pyridodioxane with the pyridine nitrogen adjacent to the dioxane and seven atoms distant from the pyrrolidine nitrogen. Indeed, this stereo/regioisomer not only maintained the alpha4beta2 affinity of [(S,R)-6], but also greatly improved in selectivity over the alpha3beta4 and alpha7 subtypes and, most importantly, exhibited a highly selective alpha4beta2 partial agonism. The finding that [(S,R)-6] is, instead, an unselective alpha4beta2 antagonist indicates that the benzodioxane substructure confers affinity for the alpha4beta2 nAChR binding site, but activation of this receptor subtype needs benzodioxane functionalization under strict steric requirements, such as the previously reported 7-OH substitution or the present isosteric modification.

From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at alpha4beta2 nicotinic acetylcholine receptor / C. Bolchi, F. Bavo, C. Gotti, L. Fumagalli, F. Fasoli, M. Binda, V. Mucchietto, M. Sciaccaluga, S. Plutino, S. Fucile, M. Pallavicini. - In: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 1768-3254. - 125(2017 Jan), pp. 1132-1144. [10.1016/j.ejmech.2016.10.048]

From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at alpha4beta2 nicotinic acetylcholine receptor

C. Bolchi;F. Bavo;L. Fumagalli;F. Fasoli;M. Binda;V. Mucchietto;M. Pallavicini
2017

Abstract

Each of the four aromatic -CH= of (S,R)-2-pyrrolidinyl-1,4-benzodioxane [(S,R)-6] and of its epimer at the dioxane stereocenter (S,S)-6, previously reported as alpha4beta2 nAChR ligands, was replaced with nitrogen. The resulting four diastereoisomeric pairs of pyrrolidinyl-pyridodioxanes were studied for the nicotinic affinity and activity at alpha4beta2, alpha3beta4 and alpha7 nAChR subtypes and compared to their common carbaisostere. It turned out that such isosteric substitutions are highly detrimental, but with the important exception of the S,R stereoisomer of the pyrrolidinyl-pyridodioxane with the pyridine nitrogen adjacent to the dioxane and seven atoms distant from the pyrrolidine nitrogen. Indeed, this stereo/regioisomer not only maintained the alpha4beta2 affinity of [(S,R)-6], but also greatly improved in selectivity over the alpha3beta4 and alpha7 subtypes and, most importantly, exhibited a highly selective alpha4beta2 partial agonism. The finding that [(S,R)-6] is, instead, an unselective alpha4beta2 antagonist indicates that the benzodioxane substructure confers affinity for the alpha4beta2 nAChR binding site, but activation of this receptor subtype needs benzodioxane functionalization under strict steric requirements, such as the previously reported 7-OH substitution or the present isosteric modification.
No
English
alpha4beta2 nAChR; alpha3beta4 nAChR; benzodioxane; pyridodioxane; partial agonism; antagonism
Settore CHIM/08 - Chimica Farmaceutica
Settore CHIM/06 - Chimica Organica
Settore BIO/14 - Farmacologia
Articolo
Esperti anonimi
Ricerca di base
Pubblicazione scientifica
gen-2017
21-ott-2016
Elsevier
125
1132
1144
13
Pubblicato
Periodico con rilevanza internazionale
IF: 6.514 Quartile: Q1
Aderisco
info:eu-repo/semantics/article
From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at alpha4beta2 nicotinic acetylcholine receptor / C. Bolchi, F. Bavo, C. Gotti, L. Fumagalli, F. Fasoli, M. Binda, V. Mucchietto, M. Sciaccaluga, S. Plutino, S. Fucile, M. Pallavicini. - In: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 1768-3254. - 125(2017 Jan), pp. 1132-1144. [10.1016/j.ejmech.2016.10.048]
reserved
Prodotti della ricerca::01 - Articolo su periodico
11
262
Article (author)
no
C. Bolchi, F. Bavo, C. Gotti, L. Fumagalli, F. Fasoli, M. Binda, V. Mucchietto, M. Sciaccaluga, S. Plutino, S. Fucile, M. Pallavicini
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0223523416309102-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 749.55 kB
Formato Adobe PDF
749.55 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/450100
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 12
social impact